NEW YORK (GenomeWeb) – Children's Hospital Oakland Research Institute (CHORI) announced today that one of its researchers has received a $13.2 million grant from the National Institute of General Medical Sciences to identify the genetic mechanisms that influence patient response to statin drugs.

To oversee the project, CHORI's Ronald Krauss and collaborators have established a Center for Pharmacogenomics in Precision Medicine, applying genomic, transcriptomic, and metabolomic tools to studies in cellular and animal models of cardiovascular disease, CHORI said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sponsored by

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.